跳至主要内容
临床试验/NCT02894450
NCT02894450已完成不适用

Study of Clinical and Laboratory Variables Associated With a Direct Oral Anticoagulant Bioassay (Xaban) Higher Among Those Aged Over 75 Years, as AOD for Atrial Fibrillation

Nantes University Hospital1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2014年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
70
试验地点
1
主要终点
bioassay direct oral anticoagulants

研究概览

简要总结

The objective of this study was to investigate whether there is a link between clinical and biological variables and bioassay high xaban in elderly patients as part of an unscheduled hospitalization.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
75 Years 至 —(Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age ≥ 75 years
  • •Entering SAU or MPG (Nantes University Hospital) as part of an unscheduled hospitalization for acute or subacute disease (About MPG, will be included patients admitted to the department within 48 hours of calling the doctor)
  • •In xaban to entry (dabigatran, rivaroxaban, Apixaban) for non-valvular atrial fibrillation
  • •In whom hemostasis tests will be prescribed as part of usual care
  • •Patient has given its verbal agreement

排除标准

  • •Patients with the following criteria may not be included:
  • •Patients refusing to participate in the study
  • •Patients under guardianship
  • •Inability to obtain the date and time of the last dose of xaban

结局指标

主要结局

bioassay direct oral anticoagulants

时间窗: Baseline

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验